SCHEMBL3259840

SCHEMBL3259840

C=CCNCCC(=O)N(CC=C)N(CCC)CCC

nearest known ligand 0.35

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
FAAH O00519 1/20 0.34
ALDH1A1 P00352 1/20 0.33
MAPT P10636 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3261672 0.91 FAAH (0.36) FAAHMAPT
SCHEMBL3259466 0.89 ALDH1A1 (0.33) FAAHALDH1A1MAPT
SCHEMBL3258271 0.89 FAAH (0.35) FAAHMAPT
SCHEMBL3261133 0.88 FAAH (0.34) FAAHALDH1A1MAPT
SCHEMBL3259814 0.87 ALDH1A1 (0.36) ALDH1A1MAPT
SCHEMBL3261399 0.83 FAAH (0.35) FAAHMAPT
SCHEMBL3258023 0.83 ALDH1A1 (0.33) FAAHALDH1A1MAPT
SCHEMBL3260225 0.83 ALDH1A1 (0.35) FAAHALDH1A1MAPT
SCHEMBL3259655 0.83 FAAH (0.37) FAAHALDH1A1MAPT
SCHEMBL3261431 0.81 FAAH (0.36) FAAHMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8937090-B2 Parakeratosis inhibitor, pore-shrinking agent and external composition for skin SHISEIDO COMPANY, LTD. (JP) 2015-01-20 US disclosed
US-20120232111-A1 Parakeratosis inhibitor, pore -shrinking agent and external compositon for skin SHISEIDO COMPANY, LTD. (JP) 2012-09-13 US disclosed
US-20120165409-A1 WRINKLE-IMPROVING AGENT SHISEIDO COMPANY, LTD. (JP) 2012-06-28 US disclosed
US-20100035881-A1 WRINKLE-IMPROVING AGENT SHISEIDO COMPANY, LTD. (JP) 2010-02-11 US disclosed
EP-1941861-A1 WRINKLE-IMPROVING AGENT Shiseido Company, Limited (JP) 2008-07-09 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100035881-A1 WRINKLE-IMPROVING AGENT AAAS, GLA, COL14A1 FAAH 907/4885ALDH1A1 1501/4885MAPT 2499/4885
US-20120232111-A1 Parakeratosis inhibitor, pore -shrinking agent and external compositon for skin CUTA, AAAS, NUP160 FAAH 2877/4885ALDH1A1 3543/4885MAPT 2324/4885
US-20120165409-A1 WRINKLE-IMPROVING AGENT AAAS, GLA, COL14A1 FAAH 915/4885ALDH1A1 1151/4885MAPT 2212/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.